Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/59038
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRavikumar, D-
dc.contributor.authorSubramanyam, Ch-
dc.contributor.authorVenkataramaiah, Ch-
dc.contributor.authorRajendra, W-
dc.contributor.authorRao, K Prasada-
dc.date.accessioned2022-02-01T11:37:25Z-
dc.date.available2022-02-01T11:37:25Z-
dc.date.issued2022-01-
dc.identifier.issn2583-1321 (Online); 0019-5103 (Print)-
dc.identifier.urihttp://nopr.niscair.res.in/handle/123456789/59038-
dc.description60-68en_US
dc.description.abstractIn the present work, a series of new phosphoramidate derivatives have been conveniently synthesized by using 4- chlorobenzene-sulfonyl chloride as preliminary material via substituted sulfonamides as intermediates with high yields in a short period by conventional and microwave irradiation techniques. All the synthesized compound have been characterized by spectral and elemental analyses. An in silico molecular docking study has been performed to find potent anti-diabetic drugs. In vitro anti-diabetic activity of the title compounds have also been screened by standard α-amylase inhibition assay. Some of the tested compounds have been proven to possess promising activity when compared with reference drug.en_US
dc.language.isoenen_US
dc.publisherNIScPR-CSIR, Indiaen_US
dc.sourceIJC Vol.61(01) [January 2022]en_US
dc.subjectPhosphoramidatesen_US
dc.subject4-chlorobenzene sulfonyl chlorideen_US
dc.subjectmolecular docking studiesen_US
dc.subjectanti-diabetic activityen_US
dc.titleSynthesis, spectral characterization and anti-diabetic activity evaluation of phosphoramidate derivativesen_US
dc.typeArticleen_US
Appears in Collections:IJC Vol.61(01) [January 2022]

Files in This Item:
File Description SizeFormat 
Indian J Chem, 61, 60-68 (Jan,2022).pdfMain Article4.99 MBAdobe PDFView/Open
Indian J Chem, 61, 60-68 (Jan,2022) Suppl. Data.pdfSupplementary Data369.12 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.